Astria Therapeutics, Inc.
ATXS
$4.04
$0.061.51%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -25.63M | -24.53M | -24.17M | -19.93M | -31.41M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.32M | 2.05M | 1.89M | 2.24M | 2.23M |
| Change in Net Operating Assets | 5.94M | -5.48M | 5.49M | -1.41M | -1.06M |
| Cash from Operations | -17.36M | -27.97M | -16.79M | -19.09M | -30.24M |
| Capital Expenditure | 0.00 | -20.00K | -305.00K | -- | -16.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.72M | 6.21M | -67.80M | -126.23M | -2.00M |
| Cash from Investing | -3.72M | 6.19M | -68.10M | -126.23M | -2.02M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 15.30M | 94.00K | 141.81M | 87.98M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 15.30M | 94.00K | 141.81M | 87.98M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -21.08M | -6.48M | -84.80M | -3.52M | 55.72M |